|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4996335A
(en)
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4789724A
(en)
|
1986-10-17 |
1988-12-06 |
Massachusetts Institute Of Technology |
Preparation of anhydride copolymers
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
CA1325382C
(en)
|
1988-01-27 |
1993-12-21 |
Takahiro Ogawa |
Locally administrable therapeutic composition for inflammatory disease
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5442039A
(en)
|
1989-07-17 |
1995-08-15 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5190956A
(en)
|
1990-09-07 |
1993-03-02 |
Schering Corporation |
Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
JPH06509576A
(ja)
|
1991-07-29 |
1994-10-27 |
ワーナー−ランバート・コンパニー |
アセチルコリンエステラーゼ阻害剤としてのキナゾリン誘導体
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
AU660852B2
(en)
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
|
GB9323290D0
(en)
|
1992-12-10 |
1994-01-05 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5364884A
(en)
|
1993-01-21 |
1994-11-15 |
Baylor College Of Medicine |
Arginine compounds as ocular hypotensive agents
|
|
US5534259A
(en)
|
1993-07-08 |
1996-07-09 |
Liposome Technology, Inc. |
Polymer compound and coated particle composition
|
|
JPH09504308A
(ja)
|
1993-07-23 |
1997-04-28 |
マサチューセッツ インスティチュート オブ テクノロジー |
非直鎖状の親水性−疎水性マルチブロックコポリマーのナノ粒子およびマイクロ粒子
|
|
US5540930A
(en)
|
1993-10-25 |
1996-07-30 |
Pharmos Corporation |
Suspension of loteprednol etabonate for ear, eye, or nose treatment
|
|
ATE173160T1
(de)
|
1994-02-17 |
1998-11-15 |
Pankaj Modi |
Arzneimittel, impfstoffe und hormone in polylaktidbeschichteten mikropartikel
|
|
AU2096895A
(en)
|
1994-03-07 |
1995-09-25 |
Sugen, Incorporated |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
GB9406094D0
(en)
|
1994-03-28 |
1994-05-18 |
Univ Nottingham And University |
Polymer microspheres and a method of production thereof
|
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
|
US5718388A
(en)
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
|
WO1997020578A1
(en)
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
|
US6046208A
(en)
|
1996-01-11 |
2000-04-04 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
EP0837063A1
(en)
|
1996-10-17 |
1998-04-22 |
Pfizer Inc. |
4-Aminoquinazoline derivatives
|
|
US6106819A
(en)
|
1996-12-31 |
2000-08-22 |
Sucher; David F. |
Methods of treating headache and functional extraocular and intraocular myotendinitis
|
|
ZA9711732B
(en)
|
1996-12-31 |
1998-12-28 |
Quadrant Holdings Cambridge |
Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
|
|
ES2196530T3
(es)
|
1997-01-06 |
2003-12-16 |
Cerus Corp |
Compuestos de ruptura para inactivar patogenos.
|
|
WO1998031346A1
(en)
|
1997-01-16 |
1998-07-23 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US7301021B2
(en)
|
1997-07-02 |
2007-11-27 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
GB9713980D0
(en)
|
1997-07-03 |
1997-09-10 |
Danbiosyst Uk |
New conjugates
|
|
ZA986729B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitors of tyrosine kinases
|
|
FR2772763B1
(fr)
|
1997-12-24 |
2004-01-23 |
Sod Conseils Rech Applic |
Nouveaux analogues tetracycliques de camptothecines, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
US6165509A
(en)
|
1998-09-01 |
2000-12-26 |
University Of Washington |
Pegylated drug complexed with bioadhesive polymer suitable for drug delivery and methods relating thereto
|
|
US6288082B1
(en)
|
1998-09-29 |
2001-09-11 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
ES2211175T3
(es)
|
1998-09-29 |
2004-07-01 |
Wyeth Holdings Corporation |
Inhibidores de proteinas de tipo tirosina quinasas a base de 3-cianoquinolinas sustituidas.
|
|
CA2344290C
(en)
|
1998-10-08 |
2009-06-02 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US6372246B1
(en)
|
1998-12-16 |
2002-04-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals
|
|
EP1146860A4
(en)
|
1999-01-08 |
2002-07-03 |
Emisphere Tech Inc |
POLYMER DRUG DELIVERY SYSTEMS AND COMPOUNDS
|
|
GB2345486A
(en)
|
1999-01-11 |
2000-07-12 |
Glaxo Group Ltd |
Heteroaromatic protein tyrosine kinase inhibitors
|
|
AU3033500A
(en)
|
1999-01-15 |
2000-08-01 |
Agouron Pharmaceuticals, Inc. |
Non-peptide glp-1 agonists
|
|
JP3270834B2
(ja)
|
1999-01-27 |
2002-04-02 |
ファイザー・プロダクツ・インク |
抗がん剤として有用なヘテロ芳香族二環式誘導体
|
|
DK1150918T3
(da)
|
1999-02-03 |
2004-12-20 |
Biosante Pharmaceuticals Inc |
Fremgangsmåde til fremstilling af terapeutiske calciumphosphatpartikler
|
|
EE05708B1
(et)
*
|
1999-02-10 |
2014-04-15 |
Astrazeneca Ab |
Kinasoliini derivaat angiogeneesi inhibiitorina ja selle kasutamine
|
|
WO2000051991A1
(en)
|
1999-02-27 |
2000-09-08 |
Boehringer Ingelheim Pharma Kg |
4-AMINO-QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANsSDUCTION MEDIATED BY TYROSINE KINASES
|
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
|
GB9910579D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
GB9910580D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
JP2004500415A
(ja)
|
2000-03-30 |
2004-01-08 |
ザ ペン ステート リサーチ ファウンデイション |
化学療法を増進するための新規な化合物
|
|
UA73993C2
(uk)
|
2000-06-06 |
2005-10-17 |
Астразенека Аб |
Хіназолінові похідні для лікування пухлин та фармацевтична композиція
|
|
NZ523358A
(en)
|
2000-08-09 |
2004-09-24 |
Astrazeneca Ab |
Quinoline derivatives having VEGF inhibiting activity
|
|
DE10042059A1
(de)
|
2000-08-26 |
2002-03-07 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
EA006711B1
(ru)
|
2000-09-11 |
2006-02-24 |
Чирон Корпорейшн |
Хинолиноновые производные в качестве ингибиторов тирозинкиназы
|
|
FR2814167B1
(fr)
|
2000-09-15 |
2002-11-08 |
Aventis Pharma Sa |
Preparation de la camptothecine et de ses derives
|
|
WO2002060868A2
(en)
|
2000-10-25 |
2002-08-08 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
AU2000202A
(en)
|
2000-10-31 |
2002-05-15 |
Pr Pharmaceuticals Inc |
Methods and compositions for enhanced delivery of bioactive molecules
|
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
|
GB2370839A
(en)
|
2001-01-06 |
2002-07-10 |
Benedikt Timmerman |
Immunogenic complex useful for disease control
|
|
US6855720B2
(en)
|
2001-03-01 |
2005-02-15 |
California Pacific Medical Center |
Nitrogen-based camptothecin derivatives
|
|
HN2002000067A
(es)
|
2001-03-23 |
2003-10-24 |
Bayer Healthcare Llc |
Inhibidores de la rho - quinasa.
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
SE0101675D0
(sv)
|
2001-05-11 |
2001-05-11 |
Astrazeneca Ab |
Novel composition
|
|
DE10128110A1
(de)
|
2001-06-11 |
2003-01-02 |
Univ Hannover |
Verbindungen zum Anlagern an Nucleinsäuren
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
AU2002350105A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel quinazolines and uses thereof
|
|
EP1408971A4
(en)
|
2001-06-21 |
2006-01-25 |
Ariad Pharma Inc |
NEW QUINOLINES AND THEIR USES
|
|
WO2003000237A2
(en)
|
2001-06-22 |
2003-01-03 |
Johns Hopkins University School Of Medicine |
Biodegradable polymer coompositions
|
|
US20050191359A1
(en)
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
|
GB0126433D0
(en)
|
2001-11-03 |
2002-01-02 |
Astrazeneca Ab |
Compounds
|
|
GB0128108D0
(en)
|
2001-11-23 |
2002-01-16 |
Astrazeneca Ab |
Therapeutic use
|
|
WO2003045920A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
|
AU2002352878B2
(en)
|
2001-11-27 |
2007-11-22 |
Merck Sharp & Dohme Corp. |
2-Aminoquinoline compounds
|
|
US7176314B2
(en)
|
2001-12-05 |
2007-02-13 |
Amgen, Inc. |
Inflammation modulators
|
|
EP1454898A4
(en)
|
2001-12-13 |
2006-12-13 |
Ajinomoto Kk |
NEW PHENYL ALANIDE DERIVATIVES
|
|
AU2002359694A1
(en)
|
2001-12-14 |
2003-06-30 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
WO2003064413A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Astrazeneca Ab |
Quinazoline compounds
|
|
US6822097B1
(en)
|
2002-02-07 |
2004-11-23 |
Amgen, Inc. |
Compounds and methods of uses
|
|
AU2006220411B2
(en)
|
2002-03-20 |
2008-06-26 |
Alkermes, Inc. |
Inhalable Sustained Therapeutic Formulations
|
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
|
WO2003101491A1
(en)
|
2002-06-03 |
2003-12-11 |
Mitsubishi Pharma Corporation |
PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR
|
|
WO2004018419A2
(en)
|
2002-08-23 |
2004-03-04 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
US20050256157A1
(en)
|
2002-08-23 |
2005-11-17 |
Chiron Corporation |
Combination therapy with CHK1 inhibitors
|
|
CA2500218A1
(en)
|
2002-09-26 |
2004-04-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug absorptivity improving agent
|
|
AU2003291362B2
(en)
|
2002-11-08 |
2009-01-15 |
Schering Corporation |
Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds
|
|
US7488823B2
(en)
|
2003-11-10 |
2009-02-10 |
Array Biopharma, Inc. |
Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
|
|
WO2004046101A2
(en)
|
2002-11-20 |
2004-06-03 |
Array Biopharma, Inc. |
Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
|
|
JP2006512387A
(ja)
|
2002-12-24 |
2006-04-13 |
アストラゼネカ アクチボラグ |
化合物
|
|
EP1575946A1
(en)
|
2002-12-24 |
2005-09-21 |
AstraZeneca AB |
Quinazoline compounds
|
|
NZ540698A
(en)
|
2002-12-24 |
2008-05-30 |
Astrazeneca Ab |
Phosphonooxy quinazoline derivatives and their pharmaceutical use
|
|
WO2004060400A1
(ja)
|
2003-01-06 |
2004-07-22 |
Mitsubishi Pharma Corp |
上皮成長因子受容体を分子標的とする抗精神病薬
|
|
US20050266090A1
(en)
|
2003-04-29 |
2005-12-01 |
Ales Prokop |
Nanoparticular targeting and therapy
|
|
WO2005044224A2
(en)
|
2003-05-02 |
2005-05-19 |
Case Western Reserve University |
Drug delivery system based on polymer nanoshells
|
|
JP2007501683A
(ja)
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
γ線照射によるナノ粒子活性物質分散体の滅菌法
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
DE10331500A1
(de)
|
2003-07-11 |
2005-02-24 |
Zentaris Gmbh |
Neue Acridin-Derivate und deren Verwendung als Arzneimittel
|
|
US20050009809A1
(en)
|
2003-07-11 |
2005-01-13 |
Matthias Gerlach |
Acridine derivatives and their use as medicaments
|
|
WO2005030131A2
(en)
|
2003-09-23 |
2005-04-07 |
Replidyne, Inc |
Bis-quinazoline compounds for the treatment of bacterial infections
|
|
WO2005035521A1
(en)
|
2003-10-09 |
2005-04-21 |
Argenta Discovery Ltd. |
Substituted quinolines as mcr modulators
|
|
AU2004288709B2
(en)
|
2003-11-07 |
2011-01-06 |
Novartis Vaccines And Diagnostics, Inc. |
Methods for synthesizing quinolinone compounds
|
|
GB0330002D0
(en)
*
|
2003-12-24 |
2004-01-28 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2005073224A2
(en)
|
2004-01-23 |
2005-08-11 |
Amgen Inc |
Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
|
|
WO2005070891A2
(en)
|
2004-01-23 |
2005-08-04 |
Amgen Inc |
Compounds and methods of use
|
|
US8957034B2
(en)
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
SE0400284D0
(sv)
|
2004-02-10 |
2004-02-10 |
Astrazeneca Ab |
Novel compounds
|
|
TW200529846A
(en)
|
2004-02-20 |
2005-09-16 |
Wyeth Corp |
3-quinolinecarbonitrile protein kinase inhibitors
|
|
CA2556872C
(en)
|
2004-02-20 |
2015-05-12 |
Chiron Corporation |
Modulation of inflammatory and metastatic processes
|
|
CN101031287A
(zh)
|
2004-03-02 |
2007-09-05 |
麻省理工学院 |
纳米细胞药物递送系统
|
|
EP1744759B1
(en)
|
2004-03-25 |
2009-09-02 |
Bausch & Lomb Incorporated |
Use of loteprednol etabonate for the treatment of dry eye
|
|
WO2005097137A2
(en)
|
2004-03-31 |
2005-10-20 |
The Scripps Research Institute |
Advanced quinazoline based protein kinase inhibitors
|
|
WO2005112938A2
(en)
|
2004-04-13 |
2005-12-01 |
Synta Pharmaceuticals Corp. |
Disalt inhibitors of il-12 production
|
|
KR20070044805A
(ko)
|
2004-04-15 |
2007-04-30 |
키아스마, 인코포레이티드 |
생물학적 장벽 투과를 촉진시킬 수 있는 조성물
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
EP1755680A1
(en)
|
2004-05-03 |
2007-02-28 |
Novartis AG |
Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor
|
|
US20100226931A1
(en)
|
2004-06-24 |
2010-09-09 |
Nicholas Valiante |
Compounds for immunopotentiation
|
|
EP1768692B8
(en)
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
JP2008505907A
(ja)
|
2004-07-06 |
2008-02-28 |
アンジオン バイオメディカ コーポレイション |
癌治療を目的として肝細胞増殖因子およびｃ−ｍｅｔ活性を調整するキナゾリンモジュレーター
|
|
WO2006030941A1
(ja)
|
2004-09-13 |
2006-03-23 |
Eisai R & D Management Co., Ltd. |
スルホンアミド含有化合物の血管新生阻害物質との併用
|
|
US8653055B2
(en)
|
2004-09-15 |
2014-02-18 |
Teva Animal Health, Inc. |
Corticosteroid having low systemic absorption
|
|
JP2008514576A
(ja)
*
|
2004-09-27 |
2008-05-08 |
アストラゼネカ アクチボラグ |
Ａｚｄ２１７１およびイマチニブを含む癌組合せ療法
|
|
KR101341359B1
(ko)
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
|
TW200616612A
(en)
|
2004-10-08 |
2006-06-01 |
Wyeth Corp |
Method for the teatment of polycystic kidney disease field of invention
|
|
US20090036474A1
(en)
|
2004-10-12 |
2009-02-05 |
Patrick Ple |
Quinazoline derivatives for use against cancer
|
|
US20060083781A1
(en)
|
2004-10-14 |
2006-04-20 |
Shastri V P |
Functionalized solid lipid nanoparticles and methods of making and using same
|
|
CA2587642C
(en)
|
2004-11-30 |
2013-04-09 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
|
CA2590098C
(en)
|
2004-12-10 |
2015-03-31 |
Justin Hanes |
Functionalized poly (ether-anhydride) block copolymers
|
|
MX2007010037A
(es)
|
2005-02-18 |
2008-02-15 |
Novartis Vaccines & Diagnostic |
Agentes antiangiogenicos con aldesleucina.
|
|
DE102005009705A1
(de)
|
2005-03-03 |
2006-09-07 |
Universität des Saarlandes |
Selektive Hemmstoffe humaner Corticoidsynthasen
|
|
WO2006092430A1
(de)
|
2005-03-03 |
2006-09-08 |
Universität des Saarlandes |
Selektive hemmstoffe humaner corticoidsynthasen
|
|
DE102005011786A1
(de)
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
US8048889B2
(en)
|
2005-03-29 |
2011-11-01 |
Xtl Biopharmaceuticals Ltd. |
3,4-disubstituted coumarin and quinolone compounds
|
|
DK1868998T3
(en)
|
2005-04-01 |
2016-08-29 |
Vfp Therapies |
NEW HETEROCYCLIC COMPOUNDS, MANUFACTURING THEM, AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-ALZHEIMER AGENTS
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
|
AU2006244244B2
(en)
|
2005-05-10 |
2010-11-04 |
Alcon, Inc. |
Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders
|
|
BRPI0609928A2
(pt)
|
2005-05-18 |
2010-05-11 |
Wyeth Corp |
inibidores de quinase tpl-2 de 3-cianoquinolina e métodos de fabricação e uso dos mesmos
|
|
WO2006127207A1
(en)
|
2005-05-25 |
2006-11-30 |
Wyeth |
Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
|
|
RU2007139544A
(ru)
|
2005-05-25 |
2009-06-27 |
Вайет (Us) |
Способ получения 3-цианохинолинов и промежуточные соединения, полученные согласно данному способу
|
|
CN1313449C
(zh)
|
2005-07-14 |
2007-05-02 |
沈阳中海生物技术开发有限公司 |
新的喹唑啉类衍生物、含有其的药物组合物以及它们的用途
|
|
JP5066446B2
(ja)
|
2005-08-01 |
2012-11-07 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
血管新生阻害物質の効果を予測する方法
|
|
JP4989476B2
(ja)
|
2005-08-02 |
2012-08-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
血管新生阻害物質の効果を検定する方法
|
|
FR2889527A1
(fr)
|
2005-08-05 |
2007-02-09 |
Servier Lab |
Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP4792262B2
(ja)
|
2005-09-09 |
2011-10-12 |
富士フイルム株式会社 |
有機電界発光素子及び錯体化合物
|
|
US7732613B2
(en)
|
2005-09-14 |
2010-06-08 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
WO2007034479A2
(en)
|
2005-09-20 |
2007-03-29 |
Yissum Research Development Company |
Nanoparticles for targeted delivery of active agents
|
|
US7875602B2
(en)
|
2005-10-21 |
2011-01-25 |
Sutter West Bay Hospitals |
Camptothecin derivatives as chemoradiosensitizing agents
|
|
CN1955183B
(zh)
|
2005-10-28 |
2011-04-20 |
中国医学科学院药物研究所 |
20-位酯化的喜树碱衍生物、其制法和其药物组合物与用途
|
|
EP1785420A1
(en)
|
2005-11-14 |
2007-05-16 |
4Sc Ag |
Thiazole analogues and uses thereof
|
|
US20070149523A1
(en)
|
2005-11-14 |
2007-06-28 |
Jan Ehlert |
Thiazole Analogues and Uses Thereof
|
|
JP5649783B2
(ja)
|
2005-12-14 |
2015-01-07 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｈｃｖプロドラッグ処方
|
|
US20070149480A1
(en)
|
2005-12-23 |
2007-06-28 |
Alcon, Inc. |
PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
US20080058312A1
(en)
|
2006-01-11 |
2008-03-06 |
Angion Biomedica Corporation |
Modulators of hepatocyte growth factor/c-Met activity
|
|
US20070196860A1
(en)
|
2006-01-18 |
2007-08-23 |
Invitrogen Corporation |
Methods for Measuring Real Time Kinase Activity
|
|
US20070178051A1
(en)
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
WO2008041960A2
(en)
|
2006-02-24 |
2008-04-10 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
US8021839B2
(en)
|
2006-02-24 |
2011-09-20 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
WO2007104696A1
(en)
|
2006-03-15 |
2007-09-20 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Antimalarial agents having polyaromatic structure
|
|
GB0605691D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic Compounds
|
|
CA2658015A1
(en)
|
2006-03-30 |
2007-10-11 |
Diatos S.A. |
Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
|
|
UY30282A1
(es)
|
2006-04-14 |
2007-11-30 |
Astrazeneca Ab |
Compuestos quimicos
|
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
CA2694955A1
(en)
|
2006-05-15 |
2007-11-22 |
Presidio Pharmaceuticals, Inc. |
3,4-disubstituted coumarin and quinolone compounds
|
|
US20100003291A1
(en)
|
2006-05-15 |
2010-01-07 |
Liquidia Technologies, Inc. |
Nano-particles for cosmetic applications
|
|
US7691811B2
(en)
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
|
JP2009539878A
(ja)
|
2006-06-08 |
2009-11-19 |
アレイ バイオファーマ、インコーポレイテッド |
キノリン化合物および使用方法
|
|
EP2044939A1
(en)
|
2006-06-29 |
2009-04-08 |
Eisai R&D Management Co., Ltd. |
Therapeutic agent for liver fibrosis
|
|
WO2008006052A2
(en)
|
2006-07-07 |
2008-01-10 |
Govek Steven P |
Bicyclic heteroaryl inhibitors of pde4
|
|
WO2008020302A2
(en)
|
2006-08-17 |
2008-02-21 |
Pfizer Products Inc. |
Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
|
|
AU2007292902B8
(en)
|
2006-09-08 |
2013-09-05 |
Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
|
EP2061469B8
(en)
|
2006-09-11 |
2014-02-26 |
Curis, Inc. |
Quinazoline based egfr inhibitors
|
|
US8821943B2
(en)
|
2006-09-12 |
2014-09-02 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
|
US20080096193A1
(en)
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
US7851623B2
(en)
|
2006-11-02 |
2010-12-14 |
Astrazeneca Ab |
Chemical process
|
|
TW200829555A
(en)
|
2006-11-10 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
|
US8414909B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US7915287B2
(en)
|
2006-12-20 |
2011-03-29 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
|
CN100540552C
(zh)
|
2007-02-01 |
2009-09-16 |
中国药科大学 |
3-氰基喹啉衍生物、其制备方法及其医药用途
|
|
CN100540551C
(zh)
|
2007-02-01 |
2009-09-16 |
中国药科大学 |
喹啉衍生物、其制备方法及其医药用途
|
|
US20080221161A1
(en)
|
2007-02-09 |
2008-09-11 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
|
JP2010519204A
(ja)
|
2007-02-16 |
2010-06-03 |
アムジエン・インコーポレーテツド |
窒素含有複素環ケトン類およびそれらのｃ−Ｍｅｔ阻害薬としての使用
|
|
JP2008214323A
(ja)
|
2007-03-08 |
2008-09-18 |
Kyowa Hakko Kogyo Co Ltd |
皮膚疾患の治療及び／または予防剤
|
|
GEP20135925B
(en)
|
2007-03-14 |
2013-10-10 |
Exelixis Patent Co Llc |
Inhibitors of hedgehog pathway
|
|
WO2008113161A1
(en)
|
2007-03-19 |
2008-09-25 |
Ulysses Pharmaceutical Products Inc. |
Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same
|
|
DE102007015169A1
(de)
|
2007-03-27 |
2008-10-02 |
Universität des Saarlandes Campus Saarbrücken |
17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
|
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
|
DE102007017654A1
(de)
|
2007-04-12 |
2008-10-16 |
Henkel Ag & Co. Kgaa |
Bis(hydroxychinolin)-Metallkomplexe als Bleichkatalysatoren
|
|
CN101317847B
(zh)
|
2007-06-06 |
2010-10-13 |
深圳市瑞谷医药技术有限公司 |
一种眼用或耳鼻用药物组合物及其用途
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
TW200904817A
(en)
|
2007-06-19 |
2009-02-01 |
Astrazeneca Ab |
Compounds and uses thereof
|
|
WO2009014730A1
(en)
|
2007-07-26 |
2009-01-29 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
|
US8535726B2
(en)
|
2007-07-27 |
2013-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Supramolecular functionalization of graphitic nanoparticles for drug delivery
|
|
CN101108846B
(zh)
|
2007-08-10 |
2011-02-09 |
东南大学 |
4-芳香氨基喹唑啉衍生物及制备方法和在制药中的应用
|
|
US20090062337A1
(en)
|
2007-08-31 |
2009-03-05 |
Wysis Technology Foundation, Inc. |
Treatment of Microbial Infections
|
|
DE102008012435A1
(de)
*
|
2008-02-29 |
2009-09-03 |
Schebo Biotech Ag |
Neue Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Therapie
|
|
WO2009030224A2
(de)
|
2007-09-07 |
2009-03-12 |
Schebo Biotech Ag |
Neue chinazolin- verbindungen und ihre verwendung zur therapie von krebserkrankungen
|
|
TW200922590A
(en)
*
|
2007-09-10 |
2009-06-01 |
Curis Inc |
VEGFR inhibitors containing a zinc binding moiety
|
|
JP2010540459A
(ja)
|
2007-09-24 |
2010-12-24 |
トラガラ ファーマシューティカルズ，インク． |
Ｃｏｘ‐２阻害薬及びｅｇｆｒ［ｅｒｂｂ１］とｈｅｒ‐２［ｅｒｂｂ２］の二重阻害薬を用いた癌を治療するための併用療法
|
|
CA2712367C
(en)
|
2008-01-17 |
2016-01-19 |
Bayer Schering Pharma Aktiengesellschaft |
Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
|
|
WO2009094211A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Quinazoline compounds and methods of treating cancer
|
|
US8133695B2
(en)
|
2008-02-28 |
2012-03-13 |
Life Technologies Corporation |
Fluorescence polarization hERG assay
|
|
AR072249A1
(es)
|
2008-04-09 |
2010-08-18 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso. usos. metodos.
|
|
WO2009140549A1
(en)
|
2008-05-14 |
2009-11-19 |
Amgen Inc. |
Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
|
|
EP2149565A1
(de)
|
2008-07-24 |
2010-02-03 |
Bayer Schering Pharma AG |
Sulfonsubstituierte Chinazolinderivate als Immunmodulatoren zur Behandlung von enzündlichen und allergischen Erkrankungen
|
|
US8211911B2
(en)
|
2008-08-19 |
2012-07-03 |
Guoqing Paul Chen |
Compounds as kinase inhibitors
|
|
TWI580441B
(zh)
|
2008-09-19 |
2017-05-01 |
愛爾康研究有限公司 |
穩定的藥學次微米懸浮液及其形成方法
|
|
MX2011004018A
(es)
*
|
2008-10-14 |
2011-06-24 |
Ning Xi |
Compuestos y metodos de uso.
|
|
WO2010056758A1
(en)
|
2008-11-12 |
2010-05-20 |
Yangbo Feng |
Quinazoline derivatives as kinase inhibitors
|
|
CN101747306B
(zh)
|
2008-11-28 |
2012-08-29 |
中国中化股份有限公司 |
取代醚类化合物及其应用
|
|
JP5471063B2
(ja)
|
2009-02-23 |
2014-04-16 |
住友化学株式会社 |
環状化合物、その金属錯体及び変性金属錯体
|
|
TWI461197B
(zh)
|
2009-03-12 |
2014-11-21 |
|
2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
|
|
US20120022057A1
(en)
|
2009-03-18 |
2012-01-26 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
|
|
US10952965B2
(en)
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
|
US9241928B2
(en)
|
2009-06-26 |
2016-01-26 |
The General Hospital Corporation |
Antimicrobial compounds
|
|
AU2010314518B2
(en)
|
2009-11-07 |
2016-04-21 |
Merck Patent Gmbh |
Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors
|
|
EP2335686A1
(en)
|
2009-12-21 |
2011-06-22 |
LEK Pharmaceuticals d.d. |
An aqueous intravenous nanosuspension with reduced adverse effects
|
|
DE102010006121B4
(de)
|
2010-01-29 |
2022-08-11 |
Merck Patent Gmbh |
Materialien für organische Elektrolumineszenzvorrichtungen
|
|
DE102010007938A1
(de)
|
2010-02-12 |
2011-10-06 |
Merck Patent Gmbh |
Elektrolumineszierende Polymere, Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
WO2011106168A1
(en)
|
2010-02-24 |
2011-09-01 |
Dcam Pharma Inc |
Purine compounds for treating autoimmune and demyelinating diseases
|
|
EP2538929A4
(en)
|
2010-02-25 |
2014-07-09 |
Univ Johns Hopkins |
DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
|
|
JP5654246B2
(ja)
|
2010-03-03 |
2015-01-14 |
一般社団法人ファルマバレープロジェクト支援機構 |
キナゾリン化合物を有効成分とする医薬組成物
|
|
TWI516264B
(zh)
|
2010-05-06 |
2016-01-11 |
臺北醫學大學 |
芳香醯喹啉化合物
|
|
DE102010023949A1
(de)
|
2010-06-16 |
2011-12-22 |
F. Holzer Gmbh |
In-situ Lecithin-Mikroemulsionsgel-Formulierung
|
|
JP5921535B2
(ja)
|
2010-06-16 |
2016-05-24 |
ディナバックス テクノロジーズ コーポレイション |
Ｔｌｒ７および／またはｔｌｒ９阻害剤を用いる治療の方法
|
|
US20120252756A1
(en)
|
2010-06-25 |
2012-10-04 |
Coffey Martin J |
Pharmaceutical Compositions and Methods for Treating, Controlling, Ameliorating, or Reversing Conditions of the Eye
|
|
WO2011163610A2
(en)
|
2010-06-25 |
2011-12-29 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
NZ603456A
(en)
|
2010-06-28 |
2014-08-29 |
Merck Patent Gmbh |
2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
|
|
WO2012012627A1
(en)
|
2010-07-22 |
2012-01-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of preventing or treating viral infection
|
|
JP5878172B2
(ja)
|
2010-07-29 |
2016-03-08 |
ラボラトワール フルニエ エスアーエス |
炎症性眼疾患の治療／予防用化合物
|
|
EP2598493A1
(en)
|
2010-07-30 |
2013-06-05 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
EP2609084A1
(en)
|
2010-08-27 |
2013-07-03 |
Grünenthal GmbH |
Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
|
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
|
WO2012038944A1
(en)
|
2010-09-24 |
2012-03-29 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
CA2812319A1
(en)
|
2010-09-24 |
2012-03-29 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
AU2011306397A1
(en)
|
2010-09-24 |
2013-05-02 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
US9597325B2
(en)
|
2010-10-13 |
2017-03-21 |
Trustees Of Boston University |
Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics
|
|
EA201390600A1
(ru)
|
2010-10-22 |
2013-09-30 |
Байнд Терапьютикс, Инк. |
Терапевтические наночастицы с сополимерами с большим молекулярным весом
|
|
DE102010050570A1
(de)
|
2010-11-05 |
2012-05-10 |
F. Holzer Gmbh |
Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors
|
|
CA3054532C
(en)
|
2010-11-05 |
2022-07-12 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
WO2012064898A1
(en)
|
2010-11-09 |
2012-05-18 |
Yuan Chen |
Singleton inhibitors of sumoylation enzymes and methods for their use
|
|
KR101813482B1
(ko)
|
2010-11-24 |
2017-12-29 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 시크리터리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시스 |
루푸스의 치료 또는 예방을 위한 조성물 및 방법
|
|
WO2012074980A2
(en)
|
2010-12-01 |
2012-06-07 |
Dara Biosciences, Inc. |
Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives
|
|
AR084433A1
(es)
|
2010-12-22 |
2013-05-15 |
Ironwood Pharmaceuticals Inc |
Inhibidores de la faah y composiciones farmaceuticas que los contienen
|
|
WO2012088431A1
(en)
|
2010-12-23 |
2012-06-28 |
Ironwood Pharmaceuticals, Inc. |
Faah inhibitors
|
|
WO2012093117A1
(en)
|
2011-01-03 |
2012-07-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases
|
|
US8980909B2
(en)
|
2011-01-12 |
2015-03-17 |
Crystal Biopharmaceutical Llc |
HDAC inhibiting derivatives of camptothecin
|
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
US20120214803A1
(en)
|
2011-02-18 |
2012-08-23 |
Vifor (International) Ag |
Novel Sulfonaminoquinoline Hepcidin Antagonists
|
|
US11179500B2
(en)
|
2011-02-24 |
2021-11-23 |
Emory University |
JAB1 inhibitory compositions for ossification and methods related thereto
|
|
WO2012127506A1
(en)
|
2011-03-22 |
2012-09-27 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
|
EP2691542A4
(en)
|
2011-03-29 |
2014-12-24 |
Trana Discovery Inc |
SCREENING PROCEDURE FOR IDENTIFICATION OF SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS
|
|
US8507686B2
(en)
|
2011-04-14 |
2013-08-13 |
Allergan, Inc. |
Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
|
|
CA2833305A1
(en)
|
2011-04-14 |
2012-10-18 |
Allergan, Inc. |
Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
|
|
CN103781766A
(zh)
|
2011-04-18 |
2014-05-07 |
阿勒根公司 |
用作鞘氨醇-1磷酸酯受体调节剂的取代的双环甲胺衍生物
|
|
WO2012149228A1
(en)
|
2011-04-26 |
2012-11-01 |
Genentech, Inc. |
Compositions and method for treating autoimmune diseases
|
|
US8835410B2
(en)
|
2011-05-10 |
2014-09-16 |
Bodor Laboratories, Inc. |
Treatment of eyelid dermatitis
|
|
EP2707006B1
(en)
|
2011-05-12 |
2019-07-03 |
Foresight Biotherapeutics, Inc. |
Stable povidone-iodine compositions with bromfenac
|
|
US20140235548A1
(en)
|
2011-05-17 |
2014-08-21 |
Cleave Biosciences, Inc. |
Compositions and methods for jamm protein inhibition
|
|
US9439884B2
(en)
|
2011-05-26 |
2016-09-13 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for the treatment of immune disorders
|
|
BR112013033417A2
(pt)
|
2011-06-29 |
2016-08-16 |
Otsuka Pharma Co Ltd |
compostos terapêuticos e métodos relacionados de uso
|
|
WO2013013614A1
(zh)
|
2011-07-28 |
2013-01-31 |
南京英派药业有限公司 |
4-(3-杂芳基芳基氨基)喹唑啉和1-(3-杂芳基芳基氨基)异喹啉作为Hedgehog通路抑制剂及其应用
|
|
JP5753027B2
(ja)
|
2011-08-22 |
2015-07-22 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子、化合物、並びに該素子を用いた発光装置、表示装置及び照明装置
|
|
TW202023575A
(zh)
|
2011-09-16 |
2020-07-01 |
美商遠景生物製藥股份有限公司 |
安定之普維酮—碘組成物
|
|
WO2013061269A1
(en)
|
2011-10-26 |
2013-05-02 |
Micro Labs Limited |
Combinations of loteprednol and olopatadine for the treatment of ocular allergies
|
|
KR101688898B1
(ko)
|
2011-11-03 |
2016-12-22 |
타이완 리포솜 캄퍼니 리미티드 |
소수성 캄프토테신 유도체의 약제 조성물
|
|
WO2013065028A1
(en)
|
2011-11-04 |
2013-05-10 |
Micro Labs Limited |
Fixed dose combination containing azithromycin and loteprednol for treatment of ocular infections
|
|
US20130116279A1
(en)
|
2011-11-07 |
2013-05-09 |
Kalypsys, Inc. |
Bicyclic heteroaryl inhibitors of pde4
|
|
WO2013070852A2
(en)
|
2011-11-08 |
2013-05-16 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
|
CN103102342B
(zh)
|
2011-11-14 |
2014-10-29 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
|
AR092289A1
(es)
|
2011-11-14 |
2015-04-15 |
Sunshine Lake Pharma Co Ltd |
Derivados de aminoquinazolina y sus sales y metodos de uso
|
|
EP2780026B1
(en)
|
2011-11-15 |
2019-10-23 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
|
CN104105507B
(zh)
|
2011-12-14 |
2020-03-24 |
约翰霍普金斯大学 |
增强粘膜渗透或减少炎症的纳米粒子
|
|
CN103183674B
(zh)
|
2011-12-31 |
2017-09-12 |
江苏先声药业有限公司 |
一类稠杂环衍生物及其应用
|
|
AR089939A1
(es)
|
2012-02-09 |
2014-10-01 |
Glenmark Pharmaceuticals Sa |
COMPUESTOS BICICLICOS COMO INHIBIDORES DE mPGES-1
|
|
CN104520255A
(zh)
|
2012-02-10 |
2015-04-15 |
加利福尼亚大学董事会 |
用于氢化硅烷化的第一排金属基催化剂
|
|
CN103304572A
(zh)
|
2012-03-09 |
2013-09-18 |
上海医药集团股份有限公司 |
一类3-氰基喹啉类化合物及其药用组合物和应用
|
|
WO2013158928A2
(en)
|
2012-04-18 |
2013-10-24 |
Elcelyx Therapeutics, Inc. |
Chemosensory receptor ligand-based therapies
|
|
NZ741873A
(en)
|
2012-05-03 |
2019-04-26 |
Kala Pharmaceuticals Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
|
KR102310775B1
(ko)
|
2012-05-03 |
2021-10-07 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
US20150148369A1
(en)
|
2012-06-01 |
2015-05-28 |
Oxalys Pharmaceuticals |
Chemical suppressors of neurotoxicity in synucleinopathic diseases
|
|
CN104583206A
(zh)
|
2012-06-15 |
2015-04-29 |
加利福尼亚大学董事会 |
用于脑癌的新颖治疗剂
|
|
EP3208270A1
(en)
|
2012-07-20 |
2017-08-23 |
Cleave Biosciences, Inc. |
Fused pyrimidines as inhibitors of p97 complex
|
|
CN103804292A
(zh)
|
2012-11-05 |
2014-05-21 |
江苏唐果医药科技有限公司 |
Hdm2和hdmx双重抑制剂3－腈基喹啉衍生物及其制备方法与应用
|
|
AU2013342203B2
(en)
|
2012-11-08 |
2017-11-23 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions and their use as PKM2 modulators
|
|
WO2014074517A1
(en)
|
2012-11-08 |
2014-05-15 |
Emory University |
Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto
|
|
WO2014074926A1
(en)
|
2012-11-09 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
|
KR102051910B1
(ko)
|
2012-11-30 |
2019-12-09 |
에스에프씨주식회사 |
중수소 치환된 유기금속 착물 및 이를 포함하는 유기 발광 소자
|
|
WO2014086284A1
(zh)
|
2012-12-04 |
2014-06-12 |
上海医药集团股份有限公司 |
一类氘代3-氰基喹啉类化合物、其药用组合物、制备方法及其用途
|
|
US20150318498A1
(en)
|
2012-12-21 |
2015-11-05 |
Merck Patent Gmbh |
Metal Complexes
|
|
KR102084421B1
(ko)
|
2013-02-15 |
2020-03-05 |
에스에프씨주식회사 |
신규한 유기 화합물 및 이를 포함하는 유기 발광 소자
|
|
CN105189462B
(zh)
*
|
2013-02-20 |
2017-11-10 |
卡拉制药公司 |
治疗性化合物和其用途
|
|
KR102118013B1
(ko)
|
2013-02-22 |
2020-06-05 |
에스에프씨주식회사 |
신규한 유기 화합물 및 이를 포함하는 유기 발광 소자
|
|
EP2964625B1
(en)
|
2013-03-04 |
2018-07-25 |
Health Sciences North Research Institute |
Quinoline sulfonyl derivatives and uses thereof
|
|
WO2014141057A2
(en)
|
2013-03-12 |
2014-09-18 |
Mahesh Kandula |
Compositions and methods for the treatment of cancer
|
|
BR112015022417A2
(pt)
|
2013-03-14 |
2017-07-18 |
Convergene Llc |
métodos e composições para inibição de proteínas contendo bromodomínio
|
|
WO2014141110A2
(en)
|
2013-03-14 |
2014-09-18 |
Curadev Pharma Pvt. Ltd. |
Aminonitriles as kynurenine pathway inhibitors
|
|
WO2014147611A1
(en)
|
2013-03-18 |
2014-09-25 |
Genoscience Pharma |
Quinolines derivatives as novel anticancer agents
|
|
EP2994142A4
(en)
|
2013-05-08 |
2017-03-29 |
Colorado Seminary, Which Owns and Operates The University of Denver |
Antibiotic and anti-parasitic agents that modulate class ii fructose 1,6-bisphosphate aldolase
|
|
WO2014186398A1
(en)
|
2013-05-16 |
2014-11-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for inhibiting drug-resistant strains of hiv-1 integrase
|
|
CN105636944B
(zh)
|
2013-10-14 |
2019-03-01 |
默克专利有限公司 |
用于电子器件的材料
|
|
AU2014342042B2
(en)
|
2013-11-01 |
2017-08-17 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|